Cargando…
Structure-based design of selective, orally available salt-inducible kinase inhibitors that stimulate bone formation in mice
Osteoporosis is a major public health problem. Currently, there are no orally available therapies that increase bone formation. Intermittent parathyroid hormone (PTH) stimulates bone formation through a signal transduction pathway that involves inhibition of salt-inducible kinase isoforms 2 and 3 (S...
Autores principales: | Sato, Tadatoshi, Andrade, Christian D. Castro, Yoon, Sung-Hee, Zhao, Yingshe, Greenlee, William J., Weber, Patricia C., Viswanathan, Usha, Kulp, John, Brooks, Daniel J., Demay, Marie B., Bouxsein, Mary L., Mitlak, Bruce, Lanske, Beate, Wein, Marc N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Academy of Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897432/ https://www.ncbi.nlm.nih.gov/pubmed/36472957 http://dx.doi.org/10.1073/pnas.2214396119 |
Ejemplares similares
-
Partial prevention of glucocorticoid-induced osteocyte deterioration in young male mice with osteocrin gene therapy
por: Mazur, Courtney M., et al.
Publicado: (2022) -
Dual targeting of salt inducible kinases and CSF1R uncouples bone formation and bone resorption
por: Tang, Cheng-Chia, et al.
Publicado: (2021) -
OR03-2 Different Effects of Abaloparatide and h-PTH(1-34) on Osteoclastogenesis and Bone Resorption
por: Arlt, Heike, et al.
Publicado: (2019) -
A parathyroid hormone/salt-inducible kinase signaling axis controls renal vitamin D activation and organismal calcium homeostasis
por: Yoon, Sung-Hee, et al.
Publicado: (2023) -
Effects of abaloparatide and teriparatide on bone resorption and bone formation in female mice()
por: Arlt, Heike, et al.
Publicado: (2020)